Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review. - PubMed - NCBI "Although
2019-03-23 12:55:10
Utility of social media and crowd-intelligence data for pharmacovigilance: a scoping review. - PubMed - NCBI
"Although social media data has the potential to supplement data from
regulatory agency databases; is able to capture less frequently reported
AEs; and can identify AEs earlier than official alerts or regulatory
changes, the utility and validity of the data source remains
under-studied."
A review of the evidence for use of social media in pharmacovigilance and patient safety.
Source: www.ncbi.nlm.nih.gov
pharmacovigilance aes data media regulatory utility social ncbi
Related: